REFERENCES

1. Song S, Guo Y, Yang Y, Fu D. Advances in pathogenesis and therapeutic strategies for osteoporosis. Pharmacol Ther. 2022;237:108168.

2. Black DM, Eastell R, Adams AL. Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates.Reply. N Engl J Med. 2020;383:2188-90.

3. Wang J, Xing F, Sheng N, Xiang Z. associations of the geriatric nutritional risk index with femur bone mineral density and osteoporosis in american postmenopausal women: data from the national health and nutrition examination survey. Front Nutr. 2022;9:860693.

4. Khosla S, Hofbauer LC. Osteoporosis treatment: recent developments and ongoing challenges. Lancet Diabetes Endocrinol. 2017;5:898-907.

5. Liu J, Curtis EM, Cooper C, Harvey NC. State of the art in osteoporosis risk assessment and treatment. J Endocrinol Invest. 2019;42:1149-64.

6. Ayers C, Kansagara D, Lazur B, Fu R, Kwon A, Harrod C. Effectiveness and safety of treatments to prevent fractures in people with low bone mass or primary osteoporosis: a living systematic review and network meta-analysis for the American college of physicians. Ann Intern Med. 2023;176:182-95.

7. Wu YL, Lin ZJ, Li CC, et al. Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study. Signal Transduct Target Ther. 2023;8:98.

8. Chen YS, Lian WS, Kuo CW, et al. Epigenetic regulation of skeletal tissue integrity and osteoporosis development. Int J Mol Sci. 2020;21:4923.

9. Yu W, Wang HL, Zhang J, Yin C. The effects of epigenetic modifications on bone remodeling in age-related osteoporosis. Connect Tissue Res. 2023;64:105-16.

10. Duan R, Fu Q, Sun Y, Li Q. Epigenetic clock: a promising biomarker and practical tool in aging. Ageing Res Rev. 2022;81:101743.

11. Jylhävä J, Pedersen NL, Hägg S. Biological age predictors. EBioMedicine. 2017;21:29-36.

12. Marioni RE, Shah S, McRae AF, et al. DNA methylation age of blood predicts all-cause mortality in later life. Genome Biol. 2015;16:25.

13. Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14:R115.

14. Hannum G, Guinney J, Zhao L, et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell. 2013;49:359-67.

15. Levine ME, Lu AT, Quach A, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). 2018;10:573-91.

16. Lu AT, Quach A, Wilson JG, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging (Albany NY). 2019;11:303-27.

17. Hillary RF, Stevenson AJ, McCartney DL, et al. Epigenetic measures of ageing predict the prevalence and incidence of leading causes of death and disease burden. Clin Epigenetics. 2020;12:115.

18. Huang M, Xu S, Liu L, et al. m6A methylation regulates osteoblastic differentiation and bone remodeling. Front Cell Dev Biol. 2021;9:783322.

19. Fernandez-Rebollo E, Eipel M, Seefried L, et al. Primary osteoporosis is not reflected by disease-specific dna methylation or accelerated epigenetic age in blood. J Bone Miner Res. 2018;33:356-61.

20. Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23:R89-98.

21. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27:1133-63.

22. Xu W, Zhang F, Shi Y, Chen Y, Shi B, Yu G. Causal association of epigenetic aging and COVID-19 severity and susceptibility: A bidirectional Mendelian randomization study. Front Med (Lausanne). 2022;9:989950.

23. Zhang F, Deng S, Zhang J, et al. Causality between heart failure and epigenetic age: a bidirectional Mendelian randomization study. ESC Heart Fail. 2023;10:pp.2903-13.

24. Pan Y, Sun X, Huang Z, et al. Effects of epigenetic age acceleration on kidney function: a Mendelian randomization study. Clin Epigenetics. 2023;15:61.

25. Liu C, Liu N, Xia Y, Zhao Z, Xiao T, Li H. osteoporosis and sarcopenia-related traits: a bi-directional Mendelian randomization study. Front Endocrinol (Lausanne). 2022;13:975647.

26. Tang F, Wang S, Zhao H, Xia D, Dong X. Mendelian randomization analysis does not reveal a causal influence of mental diseases on osteoporosis. Front Endocrinol (Lausanne). 2023;14:1125427.

27. Lin L, Luo P, Yang M, Wang J, Hou W, Xu P. Causal relationship between osteoporosis and osteoarthritis: a two-sample Mendelian randomized study. Front Endocrinol (Lausanne). 2022;13:1011246.

28. Hartwig FP, Davies NM, Hemani G, Davey Smith G. Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique. Int J Epidemiol. 2016;45:1717-26.

29. Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304-14.

30. Yu M, Hazelton WD, Luebeck GE, Grady WM. Epigenetic aging: more than just a clock when it comes to cancer. Cancer Res. 2020;80:367-74.

31. Simpson DJ, Chandra T. Epigenetic age prediction. Aging Cell. 2021;20:e13452.

32. Jiang Z, Liu X, Hu J, Zheng Y, Shen Y. Integration analysis of epigenetic-related m⁶A-SNPs associated with atrial fibrillation. CVIA. 2023:8.

33. Fuggle NR, Laskou F, Harvey NC, Dennison EM. A review of epigenetics and its association with ageing of muscle and bone. Maturitas. 2022;165:12-7.

34. Conte M, Giuliani C, Chiariello A, Iannuzzi V, Franceschi C, Salvioli S. GDF15, an emerging key player in human aging. Ageing Res Rev. 2022;75:101569.

35. McCrory C, Fiorito G, Hernandez B, et al. GrimAge outperforms other epigenetic clocks in the prediction of age-related clinical phenotypes and all-cause mortality. J Gerontol A Biol Sci Med Sci. 2021;76:741-9.

36. Reppe S, Refvem H, Gautvik VT, et al. Eight genes are highly associated with BMD variation in postmenopausal Caucasian women. Bone. 2010;46:604-12.

37. Cheishvili D, Parashar S, Mahmood N, et al. Identification of an epigenetic signature of osteoporosis in blood DNA of postmenopausal women. J Bone Miner Res. 2018;33:1980-9.

38. Del Real A, Pérez-Campo FM, Fernández AF, et al. Differential analysis of genome-wide methylation and gene expression in mesenchymal stem cells of patients with fractures and osteoarthritis. Epigenetics. 2017;12:113-22.

39. Ethans KD, MacKnight C. Hip fracture in the elderly. An interdisciplinary team approach to rehabilitation. Postgrad Med. 1998;103:167-70.

40. Lawson A, Naylor JM, Buchbinder R, et al. Combined Randomised and Observational Study of Surgery for Fractures in the Distal Radius in the Elderly (CROSSFIRE) Study Group. Surgical plating vs closed reduction for fractures in the distal radius in older patients: a randomized clinical trial. JAMA Surg. 2021;156:229-37.